IT1270905B - PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT

Info

Publication number
IT1270905B
IT1270905B ITMI932189A ITMI932189A IT1270905B IT 1270905 B IT1270905 B IT 1270905B IT MI932189 A ITMI932189 A IT MI932189A IT MI932189 A ITMI932189 A IT MI932189A IT 1270905 B IT1270905 B IT 1270905B
Authority
IT
Italy
Prior art keywords
acetylcarnosine
cataract
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
ITMI932189A
Other languages
Italian (it)
Inventor
Mark A Babizhayev
Costa Edoardo Bozzo
Original Assignee
Bruschettini Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruschettini Srl filed Critical Bruschettini Srl
Priority to ITMI932189A priority Critical patent/IT1270905B/en
Publication of ITMI932189A0 publication Critical patent/ITMI932189A0/en
Priority to AU78127/94A priority patent/AU7812794A/en
Priority to PCT/EP1994/003340 priority patent/WO1995010294A1/en
Publication of ITMI932189A1 publication Critical patent/ITMI932189A1/en
Application granted granted Critical
Publication of IT1270905B publication Critical patent/IT1270905B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI932189A 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT IT1270905B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (en) 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT
AU78127/94A AU7812794A (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
PCT/EP1994/003340 WO1995010294A1 (en) 1993-10-15 1994-10-10 Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932189A IT1270905B (en) 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT

Publications (3)

Publication Number Publication Date
ITMI932189A0 ITMI932189A0 (en) 1993-10-15
ITMI932189A1 ITMI932189A1 (en) 1995-04-15
IT1270905B true IT1270905B (en) 1997-05-13

Family

ID=11367036

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932189A IT1270905B (en) 1993-10-15 1993-10-15 PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT

Country Status (3)

Country Link
AU (1) AU7812794A (en)
IT (1) IT1270905B (en)
WO (1) WO1995010294A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2141483C1 (en) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition
NO993678L (en) * 1999-07-28 2001-01-29 Norsk Hydro As Feed for salmonids
AUPR038200A0 (en) * 2000-09-26 2000-10-19 Beta Peptide Foundation Pty Ltd, The Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
EP1551399A4 (en) 2002-09-30 2011-01-05 Mark A Babizhayev Method for topical treatment of eye disease and composition and device for said treatment
US20060116328A1 (en) * 2003-01-20 2006-06-01 Babizhayev Mark A Combined use of carnosinase inhibitor with l-carnosines and composition
WO2005041870A2 (en) 2003-10-24 2005-05-12 Ader Enterprises, Inc. Composition and method for the treatment of eye disease
US7776364B2 (en) 2006-03-24 2010-08-17 Advanced Scientific, Llc Non-surgical method for treating cataracts in mammals including man
CN106573957B (en) 2014-07-31 2021-10-26 塞巴斯蒂安诺·舒托 Derivatives from hyaluronic acid and carnosine
EP2993172B1 (en) 2014-09-04 2017-04-19 Nicox Science Ireland Nitric oxide donating carnosine compounds
IT202000014017A1 (en) 2020-06-11 2021-12-11 Fidia Farm Spa NEW DERIVATIVES OBTAINED FROM HYALURONIC ACID AND CARNOSINE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5640613A (en) * 1979-09-13 1981-04-16 Nippon Chemiphar Co Ltd Novel type remedy for peptic ulcer
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
JPH07500580A (en) * 1991-09-09 1995-01-19 ペプテック リミテッド How to treat complications and causes of diabetes

Also Published As

Publication number Publication date
AU7812794A (en) 1995-05-04
ITMI932189A1 (en) 1995-04-15
WO1995010294A1 (en) 1995-04-20
ITMI932189A0 (en) 1993-10-15

Similar Documents

Publication Publication Date Title
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
IT1302559B1 (en) ADJUSTABLE MODULAR ORTHOPEDIC BUST FOR THE TREATMENT OF ASCOLIOSIS
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
ITMI910456A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
IT1270905B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING N-ACETYLCARNOSINE FOR THE TREATMENT OF CATARACT
ITMI950958A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALCOHOL ADDICTION
IT232136Y1 (en) MACHINE FOR THE TREATMENT OF PIETRISCO SOLID
ITMI910381A1 (en) MEDICATION FOR THE TREATMENT OF DERMATITIS
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IL105285A0 (en) Compositions for the treatment of diabetes
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IT1277117B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
BR9307182A (en) Pharmaceutical compositions of 3-substituted 2-oxindol-1-carboxamides
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IT8821369A0 (en) PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis
ITMI931174A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THALASSEMIA
ITMI930966A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PSORIASIS
IT1231944B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROTOZOOSIS, ESPECIALLY OF TRIPASONOMYASIS INCLUDING D-CARNITINE OR AN ALCANOYL DERIVATIVE OF D-CARNITINE
KR890701106A (en) Use of oxoquinazoline derivatives for the treatment of hyperlipidemia
ITMI932363A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE STIMULATION OF CELLULAR REGENERATION
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029